RI
CGON icon

RTW Investments’s CG Oncology CGON Stock Holding History

RTW Investments’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$605M Buy
8,514,590
+1,529,782
+22% +$100M 5.16% 5
2026
Q1 		$473M Buy
6,984,808
+4,972,681
+247% +$282M 4.7% 6
2025
Q4 		$83.5M Buy
2,012,127
+310,911
+18% +$12.9M 0.84% 34
2025
Q3 		$68.5M Hold
1,701,216
– – 0.84% 33
2025
Q2 		$44.2M Hold
1,701,216
– – 0.63% 38
2025
Q1 		$41.7M Hold
1,701,216
– – 0.64% 33
2024
Q4 		$48.8M Buy
1,701,216
+357,142
+27% +$12.2M 0.74% 35
2024
Q3 		$50.7M Hold
1,344,074
– – 0.73% 33
2024
Q2 		$42.4M Buy
1,344,074
+930,404
+225% +$32.2M 0.66% 36
2024
Q1 		$18.2M Buy
+413,670
New +$16.9M 0.27% 50

Other funds holding CGON

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

RTW Investments's CGON Position: Q2 2026 in Review

RTW Investments increased its CG Oncology (CGON) stake by 22% in Q2 2026, buying an estimated $100M and bringing the position to 8,514,590 shares worth $605M. The position accounts for 5.16% of the portfolio, ranked #5.

RTW Investments first reported a position in CGON in Q1 2024 and has held it in 10 quarters since. 228 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • RTW Investments held 8,514,590 shares of CG Oncology worth $605M as of Q2 2026.
  • RTW Investments bought 1,529,782 CG Oncology shares in Q2 2026, an estimated $100M.
  • CG Oncology made up 5.16% of RTW Investments's portfolio in Q2 2026, its #5 holding.
  • RTW Investments first reported a position in CG Oncology in Q1 2024 and has held it in 10 quarters since.
  • 228 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on RTW Investments's 13F filing for Q2 2026, filed 14 Aug 2026.